These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 25731717)

  • 21. pH-sensitive nano-systems for drug delivery in cancer therapy.
    Liu J; Huang Y; Kumar A; Tan A; Jin S; Mozhi A; Liang XJ
    Biotechnol Adv; 2014; 32(4):693-710. PubMed ID: 24309541
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Delivering the power of nanomedicine to patients today.
    Germain M; Caputo F; Metcalfe S; Tosi G; Spring K; Åslund AKO; Pottier A; Schiffelers R; Ceccaldi A; Schmid R
    J Control Release; 2020 Oct; 326():164-171. PubMed ID: 32681950
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.
    Shapira A; Livney YD; Broxterman HJ; Assaraf YG
    Drug Resist Updat; 2011 Jun; 14(3):150-63. PubMed ID: 21330184
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nucleic acid aptamer-guided cancer therapeutics and diagnostics: the next generation of cancer medicine.
    Xiang D; Shigdar S; Qiao G; Wang T; Kouzani AZ; Zhou SF; Kong L; Li Y; Pu C; Duan W
    Theranostics; 2015; 5(1):23-42. PubMed ID: 25553096
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multifaceted transport characteristics of nanomedicine: needs for characterization in dynamic environment.
    Ozcelikkale A; Ghosh S; Han B
    Mol Pharm; 2013 Jun; 10(6):2111-26. PubMed ID: 23517188
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Application of aptamers for targeted therapeutics.
    Ray P; Viles KD; Soule EE; Woodruff RS
    Arch Immunol Ther Exp (Warsz); 2013 Aug; 61(4):255-71. PubMed ID: 23563807
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aptamer-modified nanodrug delivery systems.
    Wu Z; Tang LJ; Zhang XB; Jiang JH; Tan W
    ACS Nano; 2011 Oct; 5(10):7696-9. PubMed ID: 22023403
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nucleic acid nanotechnology for cancer treatment.
    Jin JO; Kim G; Hwang J; Han KH; Kwak M; Lee PCW
    Biochim Biophys Acta Rev Cancer; 2020 Aug; 1874(1):188377. PubMed ID: 32418899
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nanoparticles for cancer gene therapy: Recent advances, challenges, and strategies.
    Wang K; Kievit FM; Zhang M
    Pharmacol Res; 2016 Dec; 114():56-66. PubMed ID: 27771464
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent advances in nanoparticle-mediated siRNA delivery.
    Williford JM; Wu J; Ren Y; Archang MM; Leong KW; Mao HQ
    Annu Rev Biomed Eng; 2014 Jul; 16():347-70. PubMed ID: 24905873
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantum dots in cancer therapy.
    Luo G; Long J; Zhang B; Liu C; Ji S; Xu J; Yu X; Ni Q
    Expert Opin Drug Deliv; 2012 Jan; 9(1):47-58. PubMed ID: 22171712
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vivo fluorescence imaging of tumors using molecular aptamers generated by cell-SELEX.
    Shi H; Tang Z; Kim Y; Nie H; Huang YF; He X; Deng K; Wang K; Tan W
    Chem Asian J; 2010 Oct; 5(10):2209-13. PubMed ID: 20806314
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Progress in aptamer-mediated drug delivery vehicles for cancer targeting and its implications in addressing chemotherapeutic challenges.
    Zhu J; Huang H; Dong S; Ge L; Zhang Y
    Theranostics; 2014; 4(9):931-44. PubMed ID: 25057317
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aptamer-functionalized nanoparticles for medical applications: challenges and opportunities.
    Xiao Z; Farokhzad OC
    ACS Nano; 2012 May; 6(5):3670-6. PubMed ID: 22574989
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aptamer-mediated cancer gene therapy.
    Xiang D; Shigdar S; Qiao G; Zhou SF; Li Y; Wei MQ; Qiao L; Shamaileh HA; Zhu Y; Zheng C; Pu C; Duan W
    Curr Gene Ther; 2015; 15(2):109-19. PubMed ID: 25537777
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Precision gas therapy using intelligent nanomedicine.
    He Q
    Biomater Sci; 2017 Oct; 5(11):2226-2230. PubMed ID: 28937694
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Perspectives and potential applications of nanomedicine in breast and prostate cancer.
    Liu Y; Solomon M; Achilefu S
    Med Res Rev; 2013 Jan; 33(1):3-32. PubMed ID: 23239045
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Advance in the study of targeting delivery system for siRNA mediated by aptamers].
    Wang XL; Wang QQ; Song HF
    Yao Xue Xue Bao; 2012 Jul; 47(7):850-5. PubMed ID: 22993847
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aptamer: A potential oligonucleotide nanomedicine in the diagnosis and treatment of hepatocellular carcinoma.
    Ladju RB; Pascut D; Massi MN; Tiribelli C; Sukowati CHC
    Oncotarget; 2018 Jan; 9(2):2951-2961. PubMed ID: 29416827
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aptamers: a promising tool for cancer imaging, diagnosis, and therapy.
    Liu K; Lin B; Lan X
    J Cell Biochem; 2013 Feb; 114(2):250-5. PubMed ID: 22949372
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.